Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
15.57
+0.95 (6.50%)
At close: Sep 5, 2025, 4:00 PM
15.56
-0.01 (-0.06%)
After-hours: Sep 5, 2025, 4:52 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $1.64 billion as of September 5, 2025. Its market cap has decreased by -7.06% in one year.
Market Cap
1.64B
Enterprise Value
1.05B
1-Year Change
-7.06%
Ranking
Category
Stock Price
$15.57
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $1.64B, an increase of 115.52%. That is a compound annual growth rate of 18.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 1.54B | -39.08% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |